HIV - Strategic Insights Report (Page 7)

HIV

Research Highlights Changes in Body Mass Index, Blood Pressure, and Lipid Profile After Efavirenz or Dolutegravir-Based Therapy Initiation in Acute HIV Infection

A recent study has shed light on changes in body mass index (BMI), systolic and diastolic blood pressure (SBP and DBP), and lipid profile in patients initiating efavirenz/tenofovir disoproxil fumarate/emtricitabine (EFV/TDF/FTC) or dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) antiretroviral therapy (ART) regimens during acute HIV infection

HIV

Breakthrough in HIV/AIDS Treatment: Long-Term Delivery of Broadly Neutralizing Antibodies Using AAV Vector Shows Promise

Researchers from the University of Miami have made significant progress in the development of a new approach for preventing and treating HIV infection. The study, published in Nature Communications, presented a promising method of using adeno-associated virus (AAV) vector to deliver broadly neutralizing antibodies (bnAbs) for long-term HIV prevention and

HIV

Transmitted HIV-1 Drug Resistance Exceeds 10% in China, Impacts Antiretroviral Therapy Efficacy

Research conducted across 31 provincial-level administrative divisions in China between April and June 2023 has found that transmitted drug resistance (TDR) among individuals newly diagnosed with HIV-1 in China exceeds 10%. The study analyzed demographic information and blood samples from 6,654 participants and found that TDR prevalence was 11.

HIV

Breakthrough in HIV/AIDS Treatment: Researchers Discover New Combination Therapy

Researchers at the University of Campania 'Luigi Vanvitelli' in Naples, Italy, have made a significant breakthrough in HIV/AIDS treatment by exploring new combination therapies. Despite the progress of antiretroviral therapy, some patients with multidrug-resistant (MDR) HIV infection continue to struggle with the disease. The study investigated the

HIV

Rising Concerns of Pretreatment Drug Resistance in HIV/AIDS Therapy

Research conducted in Guangxi, China, from 2019 to 2022 has revealed a significant problem with pretreatment drug resistance (PDR) in HIV/AIDS therapy. The study, led by researchers from Guangxi Medical University, found that the overall prevalence of PDR was 8.4% among newly diagnosed, antiretroviral therapy (ART)-naive individuals.

HIV

High Level of HIV-1 Drug Resistance Mutations Found in Adolescents with Detectable Viremia in Cameroon

Researchers at the University of Douala in Cameroon have identified a high level of HIV-1 drug resistance mutations among adolescents with detectable viremia. The study, published in the Journal of Antimicrobial Chemotherapy, analyzed 127 plasma and paired buffy-coat samples collected from 90 adolescents between February and September 2021. The findings

HIV

Early Drug Resistance Mutations Testing and Individualized Antiretroviral Therapy in HIV/AIDS Research

In a landmark study conducted at the Mildmay-Uganda Hospital from 2018 to 2023, researchers analyzed data from 235 people living with HIV (PLHIV) and found that early drug resistance mutations testing and individualized antiretroviral therapy (ART) can significantly improve HIV treatment outcomes. The study, led by Collins Ankunda and colleagues,

HIV

HIV/AIDS Research Reveals Distinct Pulmonary Microbiome Differences Between HIV-Positive and HIV-Negative Patients

Research conducted at Fudan University in Shanghai, China, has shed light on the differences in pulmonary microbiota between HIV-positive and HIV-negative patients with pneumocystis jirovecii infection. The study, published in PLOS ONE, aimed to investigate the alterations in the pulmonary microbiota of HIV-positive and non-HIV patients following pneumocystis jirovecii infection.

HIV

HIV/AIDS Research Updates: New Insights into Immune System Diseases and Conditions

Researchers at Michigan State University have shed light on the complexities of immune system diseases and conditions, specifically HIV/AIDS. A recent case study highlights the challenge of diagnosing myopericarditis, a condition that can masquerade as a heart attack in people living with HIV. The study's findings emphasize

HIV

Housing Instability and HIV Linked to Early Onset of Aging-Related Health Conditions

Research has shown a strong correlation between housing instability and HIV infection, with both factors being associated with the early onset of aging-related health conditions, including frailty. A study published in the journal AIDS analyzed data from adults in HIV care collected during routine clinical visits at six sites within

HIV

HIV/AIDS Research Highlights Need for Improved HCV Treatment and Prevention Strategies

Research conducted at Yale University School of Medicine, in collaboration with seven diverse health department jurisdictions, has demonstrated the importance of addressing the needs of individuals coinfected with HIV and HCV. The study, published in Open Forum Infectious Diseases, highlights the benefits of direct-acting antivirals (DAAs) in achieving viral cure

Climate

76th Session of WHO Regional Committee for the Western Pacific: Prioritizing Health in a Region of 2.2 Billion

The 76th session of the WHO Regional Committee for the Western Pacific is underway in Nadi, Fiji, from October 20 to 24, representing 38 countries and areas, and focusing on health priorities for the Region's 2.2 billion people. The meeting addresses pressing challenges such as noncommunicable and

See all